(Q34270420)

1 August 2017

title

The relationship between urinary bisphenol A levels and meningioma in Chinese adults (English)

1 reference

1 August 2017

Bo Duan

1

1 reference

1 August 2017

Xuebin Hu

2

1 reference

1 August 2017

Hongyang Zhao

3

1 reference

1 August 2017

Jun Qin

4

1 reference

1 August 2017

Jie Luo

5

1 reference

1 August 2017

publication date

25 April 2012

1 reference

International Journal of Clinical Oncology

1 August 2017

published in

1 reference

1 August 2017

volume

18

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

492-497

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-012-0408-6

1 August 2017

exact match

0 references

cites work

Genetic and molecular alterations in meningiomas.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Expression of estrogen receptors alpha and beta in human meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Hormone therapy and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Exogenous hormone use and meningioma risk: what do we tell our patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Epigenetic perspective on the developmental effects of bisphenol A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

The role of Bisphenol A in shaping the brain, epigenome and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Does breast cancer start in the womb?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Growth of a meningioma in a transsexual patient after estrogen-progestin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Bisphenol A: Perinatal exposure and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Environmental estrogens and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Sex steroid hormone exposures and risk for meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0408-6

Is there an association between meningioma and hormone replacement therapy?

21 January 2018

1 reference

12 December 2020

Epidemiology of intracranial meningioma

1 reference

12 December 2020

Bisphenol A exposure is associated with in vivo estrogenic gene expression in adults

1 reference

12 December 2020

Radiation-induced meningioma: a descriptive study of 253 cases

1 reference

12 December 2020

Modulation of meningioma cell growth by sex steroid hormones in vitro

1 reference

12 December 2020

African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials

1 reference

12 December 2020

10.1007/S10147-012-0408-6

Identifiers

DOI

1 reference

1 August 2017

1 reference